恆隆地產(00101.HK)撥款1,000萬元支援香港抗疫工作 旗下物業或改作疫苗接種中心
恆隆地產(00101.HK)宣布,透過「恆隆抗疫基金2.0」撥款1,000萬元支持香港抗疫工作,並將積極研究提供旗下項目的場地作為新冠疫苗接種點,以便市民接種新冠疫苗。
基金首階段將向前線抗疫人員、抗疫的士司機及基層家庭與學童捐贈防疫和生活物資,「抗疫關愛包」將包括防疫物資與支援學童網上學習的數據卡、兒童遊戲包,以及超級市場、保健用品及湯包現金券等。物資將會分階段透過社福機構包括香港社區組織協會、聖雅各福群會、香港基督教女青年會等派發予基層家庭及學童。此外,恆隆亦將與車隊公司磋商,向需要接種新冠疫苗的基層家庭學童提供免費接載服務。
另外,公司現正與政府蹉商,將旗下項目改裝為新冠疫苗接種中心,冀鼓勵及方便更多市民接種疫苗。如有需要,恆隆抗疫基金2.0亦會撥款支持政府建造及營運「方艙醫院」,全方位支援社區抗疫設施。
恆隆地產行政總裁盧韋柏表示,本港疫情非常嚴峻,恆隆透過恆隆抗疫基金繼續支持香港的抗疫工作,為最受影響的人士及家庭提供適切援助,十分感謝公司旗下商場的租戶、社福機構及商會等協助,攜手支援社區應對新一輪疫情。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.